Literature DB >> 8530322

Sotalol facilitates spontaneous ventricular defibrillation by enhancing intercellular coupling. An entirely new mechanism for its antiarrhythmic action.

H Uchiyama1, M Manoach, E Miyachi, Y Watanabe.   

Abstract

We have previously shown that sotalol, a class III antiarrhythmic agent, helps spontaneous ventricular defibrillation in various mammalian species. Since we hypothesized that self ventricular defibrillation depends on a high degree of intercellular synchronization, and since the major electrophysiological action of sotalol causing prolongation of action potential duration (APD), cannot fully explain its defibrillating property, we carried out a series of studies to examine the effect of sotalol on intercellular myocardial coupling. Guinea pig right ventricular muscle preparations were superfused in a tissue bath and the spread of intracellularly injected fluorescent dye (Lucifer yellow CH) to the neighboring cells was studied under various conditions. When either the Ca2+ concentration of Tyrode's solution was elevated to 6 mM or the solution was made hypoxic by not bubbling O2 (n = 3 each), no spread of the injected dye was observed. The addition of 1 microM sotalol to the high Ca2+ solution or 0.5 microM to the hypoxic superfusate (n = 3 each) caused a wide spreading of the dye, thus strongly suggesting a marked improvement in the intercellular coupling. These results show an entirely new property of sotalol, i.e., enhancement of cellular synchronization, which may better explain its ability to cause spontaneous ventricular defibrillation than its class III action. Our previous demonstration of successful spontaneous ventricular defibrillation by several other agents that are known to enhance intercellular coupling but have contrasting actions on APD further substantiates our hypothesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530322     DOI: 10.1007/bf01744984

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

Review 1.  The structural-functional basis of spontaneous ventricular defibrillation.

Authors:  M Manoach; M B Basat
Journal:  Int J Cardiol       Date:  1990-02       Impact factor: 4.164

2.  Clofilum--a new antifibrillatory agent that selectively increases cellular refractoriness.

Authors:  M I Steinberg; B B Molloy
Journal:  Life Sci       Date:  1979-10-15       Impact factor: 5.037

3.  Membrane action and catecholamine release action of bretylium tosylate in normoxic and hypoxic canine Purkinje fibers.

Authors:  M Nishimura; Y Watanabe
Journal:  J Am Coll Cardiol       Date:  1983-08       Impact factor: 24.094

4.  Active modulation of electrical coupling between cardiac cells of the dog. A mechanism for transient and steady state variations in conduction velocity.

Authors:  M S Spach; J M Kootsey; J D Sloan
Journal:  Circ Res       Date:  1982-09       Impact factor: 17.367

5.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

Authors:  L M Hondeghem; D J Snyders
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

Review 6.  Sotalol.

Authors:  S H Hohnloser; R L Woosley
Journal:  N Engl J Med       Date:  1994-07-07       Impact factor: 91.245

7.  Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.

Authors:  H Nakaya; S Kimura; Y Nakao; M Kanno
Journal:  Eur J Pharmacol       Date:  1984-09-17       Impact factor: 4.432

8.  Ventricular defibrillating properties of catecholamine uptake inhibitors.

Authors:  M Manoach; M Erez; D Wozner; D Varon
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

Review 9.  How can we facilitate spontaneous termination of ventricular fibrillation and prevent sudden cardiac death? A working hypothesis.

Authors:  M Manoach; Y Watanabe
Journal:  J Cardiovasc Electrophysiol       Date:  1995-07

10.  Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics.

Authors:  R Kato; N Ikeda; S M Yabek; R Kannan; B N Singh
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

View more
  3 in total

1.  Factors determining spontaneous ventricular defibrillation.

Authors:  N Tribulova; M Manoach
Journal:  Exp Clin Cardiol       Date:  2001

2.  The protective effect of D-sotalol against hypoxia-induced myocardial uncoupling.

Authors:  M Manoach; N Tribulova; I Imanaga
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

3.  Remodelling of cardiac gap junction connexin 43 and arrhythmogenesis.

Authors:  Takashi Mayama; Ken Matsumura; Hai Lin; Koichi Ogawa; Issei Imanaga
Journal:  Exp Clin Cardiol       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.